Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

The RAM shortage could last years

April 18, 2026

NHL Stanley Cup playoffs begin with 3 Canadian teams in contention

April 18, 2026

Quebec Court of Appeal overturns sexual assault verdict for Montreal skating coach

April 18, 2026

Canadian citizenship ceremony held in Halifax museum an emotional celebration

April 18, 2026

Fans travel to support Raptors in Cleveland

April 18, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Artificial Intelligence (AI) in Medical Diagnostics Strategic Research Report 2024-2030 Featuring Agfa Healthcare, Aidoc, AliveCor, Caption Health, Elevance, HeartFlow, Intelegain, Siemens, VisualDx
Press Release

Artificial Intelligence (AI) in Medical Diagnostics Strategic Research Report 2024-2030 Featuring Agfa Healthcare, Aidoc, AliveCor, Caption Health, Elevance, HeartFlow, Intelegain, Siemens, VisualDx

By News RoomJuly 11, 20244 Mins Read
Artificial Intelligence (AI) in Medical Diagnostics Strategic Research Report 2024-2030 Featuring Agfa Healthcare, Aidoc, AliveCor, Caption Health, Elevance, HeartFlow, Intelegain, Siemens, VisualDx
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, July 11, 2024 (GLOBE NEWSWIRE) — The “Artificial Intelligence (AI) in Medical Diagnostics – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.

The global market for Artificial Intelligence (AI) in Medical Diagnostics is estimated at US$1.1 Billion in 2023 and is projected to reach US$4.4 Billion by 2030, growing at a CAGR of 22.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

However, the integration of AI into medical diagnostics must navigate several challenges to realize its full potential. Ethical concerns, data protection, and the continuous validation of AI models are paramount to ensuring that AI tools are used responsibly and effectively. The ethical use of AI must address potential biases in algorithms, ensure the protection of patient data privacy, and maintain transparency in AI-driven decision-making processes.

Regulatory bodies have begun to recognize the importance of creating robust frameworks to facilitate the safe and effective implementation of AI in healthcare. As regulatory approval for AI-based diagnostic tools grows, so does trust in these technologies, paving the way for broader adoption.

Looking forward, the role of AI in healthcare is set to expand, promising substantial improvements in patient care through more accurate diagnostics, personalized treatments, and by ultimately enhancing the overall efficiency of healthcare services.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the AI in Medical Diagnostics Software segment, which is expected to reach US$2.4 Billion by 2030 with a CAGR of a 24.2%. The AI in Medical Diagnostics Hardware segment is also set to grow at 17.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $289.3 Million in 2023, and China, forecasted to grow at an impressive 21.2% CAGR to reach $663.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Agfa Healthcare Corporation, Aidoc, AliveCor, Inc., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Key Attributes:

Report Attribute Details
No. of Pages 250
Forecast Period 2023 – 2030
Estimated Market Value (USD) in 2023 $1.1 Billion
Forecasted Market Value (USD) by 2030 $4.4 Billion
Compound Annual Growth Rate 22.4%
Regions Covered Global

MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Artificial Intelligence (AI) in Medical Diagnostics – Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

MARKET TRENDS & DRIVERS

  • AI Enhancements in Imaging Technologies Propel Early Disease Detection
  • Growth of AI Applications in Genomic Analysis Expands Personalized Medicine
  • AI-Driven Predictive Diagnostics Strengthen Patient Outcome Predictions
  • Integration of AI in Laboratory Information Systems Enhances Diagnostic Accuracy
  • Machine Learning Algorithms for Cancer Detection Throw the Spotlight on Oncology
  • Impact of AI on Reducing Diagnostic Errors and Improving Efficiency
  • AI Tools for Cardiovascular Imaging Propel Non-Invasive Diagnostics
  • Role of AI in Handling Healthcare Big Data Generates Significant Insights
  • AI-Powered Mobile Apps for Health Monitoring Drive Patient Engagement
  • Ethical AI Use in Medical Diagnostics Strengthens Patient Trust
  • Expansion of AI in Rare Disease Research and Diagnosis
  • Data Privacy Concerns and AI Regulation in Medical Practices

FOCUS ON SELECT PLAYERS

  • Agfa Healthcare Corporation
  • Aidoc
  • AliveCor, Inc.
  • Caption Health
  • Elevance Health, Inc.
  • HeartFlow
  • Intelegain Technologies
  • Siemens Healthineers AG
  • VisualDx

For more information about this report visit https://www.researchandmarkets.com/r/n613pt

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Artificial Intelligence (AI) in Medical Diagnostics Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

BitsStrategy Unveils a Quantum AI Trading App Designed for Faster, Data-Driven Trading Decisions

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

As DC Prepares for Its First-Ever Ranked Choice Voting Primary in June, New Documentary Captures the Nationwide Movement to Make Elections Work for Voters, Not Parties

Fari Launches New Book on Cambodia’s Peace Strategy and Leadership titled “The Father Who Shielded and Never Left”

iCAUR V27 Secures CATARC L3 Off-Road Certification, Solidifying Its New Energy Off-Road Capability with Robust Technology

AriseAlpha Launches AI Stock Trading Bot as Automated Investing Trends Grow Among U.S. Investors in 2026

Other World Computing Launches OWC Express 4M2 Ultra at NAB 2026 – Thunderbolt 5 Four-Slot NVMe M.2 SSD Enclosure

Other World Computing (OWC) Launches MacDrive 12 at NAB 2026 – One Solution for Complete Mac Disk Access on Windows – Including Native Encrypted APFS Support

Tradull Develops Structured Framework to Improve Visibility in Commodity Trade Processes

Editors Picks

NHL Stanley Cup playoffs begin with 3 Canadian teams in contention

April 18, 2026

Quebec Court of Appeal overturns sexual assault verdict for Montreal skating coach

April 18, 2026

Canadian citizenship ceremony held in Halifax museum an emotional celebration

April 18, 2026

Fans travel to support Raptors in Cleveland

April 18, 2026

Latest News

BitsStrategy Unveils a Quantum AI Trading App Designed for Faster, Data-Driven Trading Decisions

April 18, 2026

Nova Scotians mourn those killed in mass shooting

April 18, 2026

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

April 18, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version